Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres

Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators

(2015) Jed L. Hubbs et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Metabolism of a Serotonin-4 Receptor Partial Agonist 4-{4-[4-Tetrahydrofuran-3-yloxy)-Benzo[d]Isoxazol-3-yloxymethyl]-Piperidin-1-ylmethyl}-Tetrahydropyran-4-ol (TBPT): Identification of an Unusual Pharmacologically Active Cyclized Oxazolidine Metabolite in Human

(2013) Aarti Sawant-Basak et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators

(2012) Mathivanan Packiarajan et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease

(2012) Michael A. Brodney et al.   JOURNAL OF MEDICINAL CHEMISTRY

Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate

(2012) Xuqing Zhang et al.   ACS Medicinal Chemistry Letters

Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design

(2011) Hao Sun et al.   ACS Medicinal Chemistry Letters

Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714

(2009) Bo Feng et al.   TOXICOLOGICAL SCIENCES